232 related articles for article (PubMed ID: 9207822)
1. Serum triple-marker screening in in vitro fertilization and naturally conceived pregnancies.
Frishman GN; Canick JA; Hogan JW; Hackett RJ; Kellner LH; Saller DN
Obstet Gynecol; 1997 Jul; 90(1):98-101. PubMed ID: 9207822
[TBL] [Abstract][Full Text] [Related]
2. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
Rice JD; McIntosh SF; Halstead AC
Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658
[TBL] [Abstract][Full Text] [Related]
3. Triploidy identified through second-trimester serum screening.
Huang T; Alberman E; Wald N; Summers AM
Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
[TBL] [Abstract][Full Text] [Related]
4. Cell-free fetal DNA levels in pregnancies conceived by IVF.
Pan PD; Peter I; Lambert-Messerlian GM; Canick JA; Bianchi DW; Johnson KL
Hum Reprod; 2005 Nov; 20(11):3152-6. PubMed ID: 16006472
[TBL] [Abstract][Full Text] [Related]
5. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
Benn PA
Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
[TBL] [Abstract][Full Text] [Related]
6. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE
Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
[TBL] [Abstract][Full Text] [Related]
7. Medically assisted reproduction and second-trimester maternal serum marker screening for Down syndrome.
Muller F; Dreux S; Lemeur A; Sault C; Desgrès J; Bernard MA; Giorgetti C; Lemay C; Mirallié S; Beauchet A;
Prenat Diagn; 2003 Dec; 23(13):1073-6. PubMed ID: 14691995
[TBL] [Abstract][Full Text] [Related]
8. Maternal midtrimester serum AFP and free beta-hCG levels in in vitro fertilization twin pregnancies.
Räty R; Virtanen A; Koskinen P; Laitinen P; Forsström J; Salonen R; Mörsky P; Ekblad U
Prenat Diagn; 2000 Mar; 20(3):221-3. PubMed ID: 10719325
[TBL] [Abstract][Full Text] [Related]
9. Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies.
Bahado-Singh RO; Oz U; Shahabi S; Mahoney MJ; Baumgarten A; Cole LA
Am J Obstet Gynecol; 2000 Nov; 183(5):1114-8. PubMed ID: 11084551
[TBL] [Abstract][Full Text] [Related]
10. Maternal serum screening for fetal Down syndrome in IVF pregnancies.
Ribbert LS; Kornman LH; De Wolf BT; Simons AH; Jansen CA; Beekhuis JR; Mantingh A
Prenat Diagn; 1996 Jan; 16(1):35-8. PubMed ID: 8821850
[TBL] [Abstract][Full Text] [Related]
11. [Screening for Down syndrome using triple marker testing in the second trimester of pregnancy].
Lesin J; Skrablin S; Durić K; Suchanek E; Muzinić D; Kalafatić D; Kuvacić I; Zlopasa G; Plavec A
Lijec Vjesn; 2003; 125(3-4):55-60. PubMed ID: 12899094
[TBL] [Abstract][Full Text] [Related]
12. Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity.
Muller F; Dreux S; Dupoizat H; Uzan S; Dubin MF; Oury JF; Dingeon B; Dommergues M
Prenat Diagn; 2003 Apr; 23(4):331-5. PubMed ID: 12673641
[TBL] [Abstract][Full Text] [Related]
13. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay.
Talbot JA; Spencer K; Abushoufa RA
Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803
[TBL] [Abstract][Full Text] [Related]
14. Second-trimester maternal serum CA-125 versus estriol in the multiple-marker screening test for Down syndrome.
Wenstrom KD; Owen J; Boots L
Obstet Gynecol; 1997 Mar; 89(3):359-63. PubMed ID: 9052585
[TBL] [Abstract][Full Text] [Related]
15. First- and second-trimester Down syndrome screening markers in pregnancies achieved through assisted reproductive technologies (ART): a FASTER trial study.
Lambert-Messerlian G; Dugoff L; Vidaver J; Canick JA; Malone FD; Ball RH; Comstock CH; Nyberg DA; Saade G; Eddleman K; Klugman S; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME
Prenat Diagn; 2006 Aug; 26(8):672-8. PubMed ID: 16764012
[TBL] [Abstract][Full Text] [Related]
16. Integrated first- and second-trimester Down syndrome screening test among unaffected IVF pregnancies.
Maymon R; Shulman A
Prenat Diagn; 2004 Feb; 24(2):125-9. PubMed ID: 14974121
[TBL] [Abstract][Full Text] [Related]
17. Comparison of nuchal translucency measurement and mid-gestation serum screening in assisted reproduction versus naturally conceived singleton pregnancies.
Maymon R; Dreazen E; Rozinsky S; Bukovsky I; Weinraub Z; Herman A
Prenat Diagn; 1999 Nov; 19(11):1007-11. PubMed ID: 10589049
[TBL] [Abstract][Full Text] [Related]
18. Alternative methods of maternal weight adjustment in maternal serum screening for Down syndrome and neural tube defects.
Watt HC; Wald NJ
Prenat Diagn; 1998 Aug; 18(8):842-5. PubMed ID: 9742575
[TBL] [Abstract][Full Text] [Related]
19. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
[TBL] [Abstract][Full Text] [Related]
20. Second-trimester maternal serum alpha-fetoprotein, unconjugated estriol, and hCG levels in pregnancies with ventral wall defects.
Saller DN; Canick JA; Palomaki GE; Knight GJ; Haddow JE
Obstet Gynecol; 1994 Nov; 84(5):852-5. PubMed ID: 7524003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]